4.4 Article

Rivaroxaban in patients with abdominal aortic aneurysm and high-sensitivity C-reactive protein elevation (BANBOO): study protocol for a randomized, controlled trial

Related references

Note: Only part of the references are listed.
Article Medicine, Research & Experimental

The SPIRIT Checklist-lessons from the experience of SPIRIT protocol editors

Riaz Qureshi et al.

Summary: Crystal clear and comprehensive RCT protocols are crucial for readers to understand trial methodology and ensure all necessary information is included. SPIRIT provides guidance, but not all trialists follow it, thus additional information is prepared to assist in understanding and utilizing the SPIRIT guidance.

TRIALS (2022)

Article Pharmacology & Pharmacy

Factor Xa inhibitor rivaroxaban suppresses experimental abdominal aortic aneurysm progression via attenuating aortic inflammation

Yong Ding et al.

Summary: Rivaroxaban attenuates the progression of abdominal aortic aneurysm (AAA) induced by both angiotensin II and calcium chloride by inhibiting aortic remodeling and inflammation, suggesting it could be a promising therapeutic agent in attenuating AAA development.

VASCULAR PHARMACOLOGY (2021)

Review Cardiac & Cardiovascular Systems

Abdominal aortic aneurysms

John Anagnostakos et al.

Summary: Abdominal aortic aneurysms (AAA) are common in older adults and can lead to serious morbidity and mortality if not treated promptly. The causes include trauma, infection, and inflammatory disorders, with risk factors such as smoking, advanced age, dyslipidemia, hypertension, and coronary artery disease. The pathophysiology involves arterial insult leading to inflammation and weakening of the arterial wall, requiring monitoring of size and growth rate to prevent rupture. Management options include controlling risk factors, surgical intervention based on risk assessment, and post-operative monitoring for complications. Advancements in technology have improved the diagnosis and treatment of AAA in recent years.

PROGRESS IN CARDIOVASCULAR DISEASES (2021)

Review Medicine, General & Internal

Lack of an effective drug therapy for abdominal aortic aneurysm

J. Golledge et al.

JOURNAL OF INTERNAL MEDICINE (2020)

Review Biochemistry & Molecular Biology

Genetic and Epigenetic Mechanisms Underlying Vascular Smooth Muscle Cell Phenotypic Modulation in Abdominal Aortic Aneurysm

Rijan Gurung et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)

Article Cardiac & Cardiovascular Systems

Efficacy of Telmisartan to Slow Growth of Small Abdominal Aortic Aneurysms: A Randomized Clinical Trial

Jonathan Golledge et al.

JAMA CARDIOLOGY (2020)

Review Pharmacology & Pharmacy

Pharmacological Therapy of Abdominal Aortic Aneurysm: An Update

Yi-dong Wang et al.

CURRENT VASCULAR PHARMACOLOGY (2018)

Article Cardiac & Cardiovascular Systems

Inhibition of interleukin-1 suppresses angiotensin II-induced aortic inflammation and aneurysm formation

Kikuo Isoda et al.

INTERNATIONAL JOURNAL OF CARDIOLOGY (2018)

Editorial Material Cardiac & Cardiovascular Systems

Will Reducing Inflammation Reduce Vascular Event Rates?

Paul M. Ridker et al.

JACC-CARDIOVASCULAR IMAGING (2018)

Editorial Material Cardiac & Cardiovascular Systems

Has the time finally come to measure hsCRP universally in primary and secondary cardiovascular prevention?

Paul M. Ridker et al.

EUROPEAN HEART JOURNAL (2018)

Article Medicine, General & Internal

Rivaroxaban or Aspirin for Extended Treatment of Venous Thromboembolism

J. I. Weitz et al.

NEW ENGLAND JOURNAL OF MEDICINE (2017)

Review Medicine, General & Internal

Association of high sensitivity C-reactive protein and abdominal aortic aneurysm: a meta-analysis and systematic review

Yunpeng Wang et al.

CURRENT MEDICAL RESEARCH AND OPINION (2017)

Article Pharmacology & Pharmacy

FXa inhibition by rivaroxaban modifies mechanisms associated with the pathogenesis of human abdominal aortic aneurysms

Guillermo Monux et al.

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2017)

Review Cardiac & Cardiovascular Systems

A Test in Context High-Sensitivity C-Reactive Protein

Paul M. Ridker

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2016)

Review Medicine, Research & Experimental

Review and publication of protocol submissions to Trials - what have we learned in 10 years?

Tianjing Li et al.

TRIALS (2016)

Article Cardiac & Cardiovascular Systems

Prediction of abdominal aortic aneurysm calcification by means of variation of high-sensitivity C-reactive protein

Emirena Garrafa et al.

JRSM CARDIOVASCULAR DISEASE (2016)

Article Cardiac & Cardiovascular Systems

Two C-C Family Chemokines, Eotaxin and RANTES, Are Novel Independent Plasma Biomarkers for Abdominal Aortic Aneurysm

Gregory T. Jones et al.

JOURNAL OF THE AMERICAN HEART ASSOCIATION (2016)

Article Cardiac & Cardiovascular Systems

Effects of Rivaroxaban on Platelet Activation and Platelet-Coagulation Pathway Interaction: In Vitro and In Vivo Studies

Elisabeth Perzborn et al.

JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS (2015)

Article Surgery

Statin use and rupture of abdominal aortic aneurysm

H. Wemmelund et al.

BRITISH JOURNAL OF SURGERY (2014)

Article Sport Sciences

A Randomized Trial of Exercise Training in Abdominal Aortic Aneurysm Disease

Jonathan Myers et al.

MEDICINE AND SCIENCE IN SPORTS AND EXERCISE (2014)

Review Hematology

Targeting factor Xa and thrombin: impact on coagulation and beyond

Charles T. Esmon

THROMBOSIS AND HAEMOSTASIS (2014)

Article Medical Laboratory Technology

Combined Cathepsin S and hs-CRP predicting inflammation of Abdominal Aortic Aneurysm

Yanwen Qin et al.

CLINICAL BIOCHEMISTRY (2013)

Article Medicine, General & Internal

SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials

An-Wen Chan et al.

BMJ-BRITISH MEDICAL JOURNAL (2013)

Article Medicine, Research & Experimental

TGF-β activity protects against inflammatory aortic aneurysm progression and complications in angiotensin II-infused mice

Yu Wang et al.

JOURNAL OF CLINICAL INVESTIGATION (2010)

Article Surgery

Markers of inflammation in men with small abdominal aortic aneurysm

Duncan J. Parry et al.

JOURNAL OF VASCULAR SURGERY (2010)

Article Medicine, General & Internal

Oral Rivaroxaban for Symptomatic Venous Thromboembolism.

Rupert Bauersachs et al.

NEW ENGLAND JOURNAL OF MEDICINE (2010)